The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Off-label prescriptions in cancer: Who should pay for them?
A. Negro
No relevant relationships to disclose
E. G. J. Rivarola
No relevant relationships to disclose
E. Gil Deza
No relevant relationships to disclose
M. Muino
No relevant relationships to disclose
E. L. Morgenfeld
No relevant relationships to disclose
D. Juarez
No relevant relationships to disclose
S. Aguirre
No relevant relationships to disclose
F. Negro
No relevant relationships to disclose
M. L. Fischer
No relevant relationships to disclose
M. J. Nacul
No relevant relationships to disclose
M. Abal
No relevant relationships to disclose
S. L. Ares
No relevant relationships to disclose
C. Garcia Gerardi
No relevant relationships to disclose
M. Montiel
No relevant relationships to disclose
F. G. Gercovich
No relevant relationships to disclose